Cango Inc. Receives Notice Regarding NYSE Continued Listing Standard

Rhea-AI Summary

Cango (NYSE: CANG) received a March 10, 2026 NYSE notice that its Class A ordinary shares failed the NYSE $1.00 minimum price standard because the 30-trading-day average closing price ended March 9, 2026, was below $1.00. The company has a six-month Cure Period to regain compliance by meeting $1.00 closing and 30-day average thresholds on the last trading day of any calendar month.

Cango says it will monitor market conditions, is considering options to cure the deficiency, and that the notice does not affect operations, SEC reporting, or credit agreements.

Positive

• Shares continue trading on NYSE during six-month Cure Period
• Company retains full SEC reporting and credit obligations

Negative

• 30-day average closing price fell below $1.00 as of March 9, 2026
• Risk of NYSE suspension and delisting if compliance not regained

News Market Reaction – CANG

+4.60%

9 alerts

+4.60% Session close to close

+19.3% Peak Tracked

-5.9% Trough Tracked

$169.36M Market Cap

1.0x Rel. Volume

In the Apr 1 session, CANG gained 4.60%, reflecting a moderate positive market reaction. Argus tracked a peak move of +19.3% during that session. Argus tracked a trough of -5.9% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details that Cango’s average share price fell below the NYSE’s US$1.00 minimum ove...

Analysis

This announcement details that Cango’s average share price fell below the NYSE’s US$1.00 minimum over 30 trading days, triggering a six‑month Cure Period to regain compliance. Shares were at US$0.411, well under the 2.97 200‑day moving average, and the stock had already reacted negatively to prior large losses and equity financings. Alongside an unused US$500,000,000 F-3 shelf, investors may focus on how Cango addresses listing compliance, capital structure, and its evolving Bitcoin and AI compute strategy.

Key Figures

NYSE minimum price: US$1.00 per share Non-compliance period: 30 trading days Notice date: March 10, 2026 +5 more

8 metrics

NYSE minimum price US$1.00 per share Continued listing price requirement under NYSE rules

Non-compliance period 30 trading days Average closing price below US$1.00 as of March 9, 2026

Notice date March 10, 2026 NYSE letter notifying Cango of price non-compliance

Cure period length Six months Time allowed to regain NYSE price compliance

Compliance thresholds US$1.00 close and 30-day average Required on last trading day of any month in Cure Period

Current share price US$0.411 Pre-news price, below NYSE US$1.00 standard

Price change 20.67% 24h move prior to publication

Shelf capacity US$500,000,000 Maximum aggregate amount under F-3 shelf registration

Historical Context

5 past events · Latest: Mar 16 (Negative)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 16	Full-year earnings	Negative	-16.7%	Unaudited 2025 results with large net loss and impairments.
Mar 13	Earnings date set	Neutral	+10.4%	Announcement of timing and access details for 2025 results call.
Mar 06	Operations update	Neutral	-0.3%	February 2026 Bitcoin production and AI/energy platform progress update.
Feb 12	Equity investment	Positive	-9.3%	US$10.5M equity close and US$65M additional investments from insiders.
Feb 12	Equity investment	Positive	-9.3%	Details on insider-led equity funding to support AI/compute expansion.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history shows negative reactions around large losses and equity financings, while neutral operational and scheduling updates had modest or mixed impact.

Recent Company History

Over the past few months, Cango reported sizeable 2025 results, including a net loss from continuing operations and an NYSE direct listing, which was followed by a -16.67% move after earnings on Mar 16, 2026. Neutral items like the earnings date announcement and the February computing and energy operations update saw limited price impact. Insider-led equity investments totaling over US$75.5M on Feb 12, 2026 coincided with a -9.35% reaction. Today’s NYSE continued listing notice adds a new regulatory overhang on top of these financial and strategic developments.

Key Terms

new york stock exchange, continued listing standard, consolidated tape, cure period, +1 more

5 terms

new york stock exchange regulatory

"letter from the New York Stock Exchange (the "NYSE") dated March 10, 2026"

The New York Stock Exchange is a marketplace where people buy and sell shares of publicly traded companies. It functions like a busy trading hub, helping investors transfer ownership of company parts and providing a way to gauge how well businesses are doing. Its role is vital because it offers liquidity and transparency, making it easier for investors to buy and sell investments confidently.

continued listing standard regulatory

"NYSE's price criteria for continued listing standard because, as of March 9, 2026"

Continued listing standards are the ongoing rules a stock exchange or trading venue requires a company to meet to keep its shares listed, such as minimum share price, market value, shareholder equity, and timely financial reporting. For investors, these standards matter because failure to meet them can trigger warnings or removal from the exchange, which can reduce a stock’s visibility, trading liquidity, and value—similar to how failing building inspections can limit a business’s ability to operate publicly.

consolidated tape technical

"average closing price of its security as reported on the consolidated tape"

A consolidated tape is a continuous electronic feed that combines real-time trade prices and sizes for a given security from all participating exchanges and trading venues into one unified stream. It matters to investors because it shows the best available prices and overall market activity at a glance—like a single live scoreboard combining results from many stadiums—helping assess fair value, compare execution quality, and make timely trading decisions.

View in glossary

cure period regulatory

"The Company has six months ("the Cure Period") following receipt of the notice"

A cure period is a set amount of time given to a borrower, counterparty, or contracting party to fix a missed payment, breach, or other problem before more serious consequences—like penalties, higher interest, or contract termination—kick in. For investors, it matters because it creates a short grace window that can prevent immediate losses and influence the timing and likelihood of recovery; think of it like a few extra days to pay a bill before a service is cut off.

securities and exchange commission regulatory

"does not affect the Company's business operations, its Securities and Exchange Commission reporting"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DALLAS, April 1, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") dated March 10, 2026, notifying the Company that it is not in compliance with the NYSE's price criteria for continued listing standard because, as of March 9, 2026, the average closing price of the Company's Class A ordinary shares was less than US$1.00 per share over a consecutive 30 trading-day period. This press release is issued within the 30-day period following receipt of such notice as required under the NYSE rules.

Pursuant to Section 802.01C of the NYSE's Listed Company Manual, a company will be considered to be below compliance standards if the average closing price of its security as reported on the consolidated tape is less than US$1.00 over a consecutive 30 trading-day period. The Company has six months ("the Cure Period") following receipt of the notice to regain compliance with the minimum share price requirement. The Company can regain compliance at any time during the Cure Period if on the last trading day of any calendar month during the Cure Period the Company has a closing share price of at least US$1.00 and an average closing share price of at least US$1.00 over the 30 trading-day period ending on the last trading day of that month. In the event that at the expiration of the six-month Cure Period, both a US$1.00 closing share price on the last trading day of the Cure Period and a US$1.00 average closing share price over the 30 trading-day period ending on the last trading day of the Cure Period are not attained, the NYSE will commence suspension and delisting procedures.

To address this issue, the Company intends to monitor the market conditions of its listed securities and is still considering its options. As required by the NYSE rules, the Company has notified the NYSE of its intent to cure the price deficiency of its Class A ordinary shares within the applicable time period required by the NYSE. During the Cure Period, the Company's Class A ordinary shares will continue to be listed and traded on the NYSE, subject to its compliance with other NYSE continued listing standards and other rights of the NYSE to delist the Class A ordinary shares. The NYSE notification does not affect the Company's business operations, its Securities and Exchange Commission reporting requirements, credit agreements or other contractual obligations.

About Cango Inc.

Cango Inc. (NYSE: CANG) is a Bitcoin mining company with a vision to establish an integrated, global infrastructure platform capable of powering the future digital economy. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa.

Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through AutoCango.com.

For more information, please visit: www.cangoonline.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about Cango's beliefs and expectations, are forward-looking statements. These statements are based on Cango's current expectations and assumptions and are not guarantees of future performance. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Cango's goal and strategies; Cango's expansion plans; Cango's future business development, financial condition and results of operations; Cango's expectations regarding demand for, and market acceptance of, its solutions and services; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Cango's filings with the Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Cango does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cango-inc-receives-notice-regarding-nyse-continued-listing-standard-302731267.html

SOURCE Cango Inc.

FAQ

What did Cango (CANG) disclose about the NYSE notice on April 1, 2026?

Cango said it received a March 10, 2026 NYSE notice for failing the $1.00 price standard. According to the company, the 30-trading-day average as of March 9, 2026, was below $1.00, triggering the six-month Cure Period to regain compliance.

How long does Cango (CANG) have to regain NYSE compliance after the March 10, 2026 notice?

Cango has a six-month Cure Period to regain compliance. According to the company, it can cure by achieving a $1.00 closing price and a $1.00 30-day average on the last trading day of any calendar month during that period.

What are the specific price conditions for Cango (CANG) to regain NYSE listing status?

To regain compliance, Cango must meet a $1.00 closing price and a $1.00 30-trading-day average on the last trading day of a calendar month. According to the company, meeting both metrics ends the deficiency before Cure Period expiration.

Will the NYSE notice affect Cango's (CANG) business operations or SEC filings?

No immediate operational impact is expected from the notice. According to the company, the NYSE notification does not affect its business operations, SEC reporting requirements, credit agreements, or other contractual obligations.

What happens if Cango (CANG) fails to cure the price deficiency by the Cure Period deadline?

If Cango fails to meet the $1.00 closing and 30-day average by Cure Period end, NYSE delisting procedures will begin. According to the company, failure to attain both metrics on the last trading day could lead to suspension and delisting.